Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sung H. Lee

Sung H. Lee is recorded as CFO at Cytokinetics Inc (CYTK). Cytokinetics Inc reported in an 8-K filed April 26, 2024 that Sung H. Lee was appointed Executive Vice President, Chief Financial Officer, effective May 8, 2024. The proxy statement of Cytokinetics Inc reports total compensation of $3,770,807 for Sung H. Lee in fiscal 2025, including a base salary of $572,918. Disclosed compensation is on record for 2 fiscal years.

“On April 23, 2024, Cytokinetics, Incorporated (the "Company") entered into an employment offer letter (the "Offer Letter") with Sung H. Lee, pursuant to which Mr. Lee has agreed to serve as the Company's Executive Vice President ("EVP"), Chief Financial Officer, effective as of May 8, 2024 (the "Start Date").”
Cytokinetics Inc Form 8-K, filed April 26, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Cytokinetics Inc

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Cytokinetics Inc (CYTK) $572,918 $3,770,807
2024 Cytokinetics Inc (CYTK) $356,251 $5,725,873

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.